Michael S. Ryan, Inc. Merck & Co., Inc. Transaction History
Michael S. Ryan, Inc.
- $135 Million
- Q1 2025
A detailed history of Michael S. Ryan, Inc. transactions in Merck & Co., Inc. stock. As of the latest transaction made, Michael S. Ryan, Inc. holds 3,817 shares of MRK stock, worth $302,191. This represents 0.25% of its overall portfolio holdings.
Number of Shares
3,817
Previous 3,923
2.7%
Holding current value
$302,191
Previous $390,000
12.31%
% of portfolio
0.25%
Previous 0.27%
Shares
6 transactions
Others Institutions Holding MRK
# of Institutions
3,954Shares Held
1.86BCall Options Held
16MPut Options Held
15M-
Vanguard Group Inc Valley Forge, PA251MShares$19.9 Billion0.45% of portfolio
-
Black Rock Inc. New York, NY207MShares$16.4 Billion0.59% of portfolio
-
State Street Corp Boston, MA121MShares$9.57 Billion0.49% of portfolio
-
Geode Capital Management, LLC Boston, MA61.2MShares$4.84 Billion0.48% of portfolio
-
Morgan Stanley New York, NY44.2MShares$3.5 Billion0.32% of portfolio
About Merck & Co., Inc.
- Ticker MRK
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,533,280,000
- Market Cap $201B
- Description
- Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...